Study details
Enrolling now
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Brown University
NCT IDNCT04135846ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
184
Study length
about 6 years
Ages
18+
Locations
1 site in RI
What this study is about
This trial is testing whether a medication called doxazosin helps people with alcohol use disorder. Participants will receive either doxazosin or a placebo, and it will last approximately 2 years.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Doxazosin
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
doxazosin
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Alcohol consumption
Body systems
Psychiatry / Mental Health